Pulmonary infection, and not systemic inflammation, accounts for increased concentrations of exhaled nitric oxide in patients with septic shock

J Breath Res. 2013 Sep;7(3):036003. doi: 10.1088/1752-7155/7/3/036003. Epub 2013 Jul 18.

Abstract

Nitric oxide (NO) is a key mediator in the pathophysiology of septic shock that can be measured in exhaled breath. To assess whether a pulmonary infection itself or systemic inflammation is responsible for NO production, we determined exhaled NO in ventilated patients with respiratory and non-respiratory septic shock and compared it with the concentration in ventilated intensive care patients without systemic inflammation. In addition, the change of NO production over time and correlations with haemodynamic instability were evaluated. The controls without systemic inflammation, as witnessed by the absence of systemic inflammatory response syndrome criteria and low levels of interleukin-6, had similar concentrations of NO as the patients with non-respiratory septic shock. The respiratory sepsis patients exhaled more NO than the non-respiratory sepsis patients (p = 0.05), and a time dependent decline in time in both groups (p = 0.04). Exhaled NO did not correlate with markers of disease severity, systemic inflammation and haemodynamic instability. These data indicate that the infected lungs are the source of exhaled NO.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers / analysis
  • Breath Tests
  • Exhalation
  • Female
  • Follow-Up Studies
  • Humans
  • Inflammation / metabolism*
  • Lung / metabolism*
  • Male
  • Middle Aged
  • Nitric Oxide / analysis*
  • Pneumonia / metabolism*
  • Prospective Studies
  • Shock, Septic / etiology
  • Shock, Septic / metabolism*

Substances

  • Biomarkers
  • Nitric Oxide